Escherichia coli GutM4 produces 2, 5-diketopiperazines and inhibits human pathogens in vitro
Electron. j. biotechnol; 28 (), 2017
Background: It has been a very common practice to use probiotics or their metabolites as alternative antimicrobial strategies for the treatment and prevention of infections as rampant and indiscriminate use of antibiotics causes the development of antibiotic-resistant pathogens. The objective of this stu...
Escherichia coli/metabolismo, Dicetopiperazinas/metabolismo, Dicetopiperazinas/farmacología, Técnicas In Vitro, Heces/microbiología, Probióticos/farmacología, Probióticos/metabolismo, Candida albicans/efectos de los fármacos, Bacterias/efectos de los fármacos, Escherichia coli/aislamiento & purificación, Microbioma Gastrointestinal, Péptidos